VivoSim Labs
VIVS
78 hedge funds and large institutions have $22.6M invested in VivoSim Labs in 2019 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 12 increasing their positions, 23 reducing their positions, and 14 closing their positions.
39% more capital invested
Capital invested by funds: $16.3M → $22.6M (+$6.29M)
7% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 14
0% more funds holding
Funds holding: 78 → 78 (0)
0% more ownership
Funds ownership: 0.2% → 0.2% (+0%)
48% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 23
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $11K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$516K |
| 2 |
Renaissance Technologies
New York
|
+$231K |
| 3 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$215K |
| 4 |
AAS
Avantax Advisory Services
Dallas,
Texas
|
+$16K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$11K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$170K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$85.5K |
| 3 |
Millennium Management
New York
|
-$73.9K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$39.4K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$33K |
VIVS Hedge Fund Activity: Q4 2019 in Review
78 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in VivoSim Labs (VIVS) for Q4 2019, worth a combined $22.6M — up 39% from $16.3M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new VIVS positions and 14 closed out — a net gain of 1 holder — while 12 added to existing stakes and 23 trimmed.
The largest buyer was Essex Investment Management, opening a new position worth an estimated $516K. The largest seller was UBS Group, cutting an estimated $170K.
- 78 institutional investors held VivoSim Labs (VIVS) as of Q4 2019, unchanged from Q3 2019.
- Funds reported $22.6M of VivoSim Labs stock for Q4 2019, up 39% quarter-over-quarter.
- 15 funds opened new VivoSim Labs positions in Q4 2019 and 14 closed out, a net change of +1 holder.
- The largest VivoSim Labs buyer in Q4 2019 was Essex Investment Management, an estimated $516K added.
- The largest VivoSim Labs seller in Q4 2019 was UBS Group, an estimated $170K sold.
Based on aggregated 13F filings for Q4 2019.